Navigation Links
New TB Vaccine Passes Safety Trial
Date:4/8/2009

Experimental preparation was tested in people with latent infection,,

WEDNESDAY, April 8 (HealthDay News) -- An experimental tuberculosis vaccine called MVA85A proved safe in a small phase I clinical trial.

The study included 12 people with latent tuberculosis infection, which, when re-activated, can cause full-blown TB. It's believed that about a third of the world's population has this latent infection. The participants, who had no other complicating factors, such as hepatitis or HIV, were given the vaccine and then followed for a year.

The researchers concluded that the vaccine was safe, did not produce any immunopathology and was immunogenic in the patients. Some participants had side effects that included fever, headache, fatigue and mild concerns at the site of the vaccination.

The findings appear in the April 15 issue of the American Journal of Respiratory and Critical Care Medicine.

This study could be an important step forward in efforts to introduce a new vaccine to fight TB, according to the researchers, led by Dr. Helen McShane, of the University of Oxford in England. They noted that any new vaccine must be developed with latent TB infection in mind because it might decrease the effectiveness of new vaccines or worsen vaccine-related side effects.

"A more effective vaccine regimen than the currently available bacillus Calmette-Guerin would have a major impact on the global TB burden and, ultimately, will be the most efficient way to control this pandemic," the researchers wrote.

They noted that larger trials of the vaccine "are needed in TB endemic areas to assess the efficacy of this vaccine against the development of TB disease, but these results are very encouraging and justify the further development of this vaccine."

More information

The American Lung Association has more about

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay
2. Hard To Treat Diseases (HTDS) Offers Hepatitis A Vaccine in India
3. U.S. Adults Needlessly Vulnerable to Vaccine-Preventable Diseases, According to New Report
4. Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis
5. Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
6. Hard to Treat Diseases (HTDS) clinical trial protocol for MMR Vaccine expected Q2 2009
7. Oral Yogurt Vaccine Could Blunt Ouch Factor
8. HPV Data May Aid Vaccines Effectiveness
9. Saving Vaccines with SensoTech's Breakthrough in Vaccine Temperature Monitoring
10. HARD TO TREAT DISEASES (HTDS) Influenca Vaccine (MEVAC-FLU) Enters Chilean Market
11. TB vaccine developed at McMaster University in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New TB Vaccine Passes Safety Trial
(Date:9/22/2014)... Alan Mozes HealthDay Reporter ... take note: Many American parents are aware of online physician-rating ... a pediatrician for their children, according to a new national ... than 1,600 parents -- further suggest that negative online ratings ... doctor has been recommended by a neighbor. Conversely, a ...
(Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
(Date:9/22/2014)... 22, 2014. Kessler researchers have published a pilot ... wellness program in people with multiple sclerosis (MS). ... health, perceived stress, and pain. "Development and ... living with MS: Description and outcomes" was epublished ... International Journal of MS Care (doi: ...
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- Two new prescription devices ... may provide some relief for people with migraine headaches ... new study. One device -- the Cefaly -- ... -- the Cerena -- is meant to be used ... release. "Patients have been looking for alternative migraine ...
(Date:9/22/2014)... weather can occur with little warning, so it’s important to be ... Month, Amica Insurance is offering the following tips to ... , Build an emergency supply kit. It should contain first-aid ... per person per day for at least 72 hours. , ... your family knows what to do and where to go if ...
Breaking Medicine News(10 mins):Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Amica Shares Tips for National Preparedness Month 2
... UK after a successful bypass surgery in Delhi at a ... tourism.// ,Mavis Childs, 67, waited for more than two ... (NHS). But she opted for India when the operation was ... ,Childs, based in Wombourne, near Wolverhampton, says she traveled ...
... In a startling discovery, researchers have found that more ... several species that are popular pets. // , ... on Nov. 16), revealed that the symptoms like pain ... to the bacteria that thrive on bits of meat ...
... known as Kyolic may decrease the risk of heart ... to UK scientists.// ,Dr. Khalid Rhaman and colleagues ... supplementation of Kyolic brand aged garlic extract inhibits platelet ... blood clots. Clot formation inside healthy blood vessels is ...
... Another plant extract called Forskolin has been found to be ... cells in cultures and mice by up to 90 percent.// ... coleus forskohlii, a native of India that is used as ... plant in the US., ,CML, a malignant cancer of ...
... and Industry magazine says that tropical plants imported from ... and other related illnesses. // ,The Asian tiger ... this species was detected in the Netherlands leading to ... mosquitoes were detected in imported bamboo in a greenhouse ...
... some kinds of live mutated viruses can cure tumors in ... of Glasgow treated a patient with an aggressive //form of ... New Scientist reported. ,A mutation of the herpes virus ... four months to live in 1997. But, eight years later ...
Cached Medicine News:Health News:British Grandmother has timely bypass surgery in India 2Health News:More Lizards, Including Pets, Found Venomous 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 3
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
(Date:9/22/2014)... 22, 2014  Olympus, a global technology leader ... and surgical procedures, among other core businesses, announced ... Munich -based Brainlab to be the ... This agreement applies to the US ENT market; ... and all distribution outside the U.S. The system, ...
(Date:9/22/2014)... 2014  Sutro Biopharma today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Sutro has earned some careful ... as industry partners for what promises to be a ... John Carroll , editor of FierceBiotech .  ...
Breaking Medicine Technology:Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3
... 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... China , announced today that it,will release its financial results for ... of the market on Monday, August 16, 2010 . The ... at 8:00 a.m. ET to review,the Company,s financial ...
... Advanced Brain Technologies today announced results demonstrating that a modified ... Down syndrome. The results of the study, conducted in Nottingham, United ... of the article scheduled to appear in the journal Music and Medicine(i). ... It ...
Cached Medicine Technology:Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 2Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 3Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 2Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: